PROLIA
Google image searchProduct monograph
Active ingredient
denosumab, 60 MG/ML
DIN: 02343541
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PRE-FILLED SYRINGE. PRESERVATIVE-FREE.
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 12-AUG-2010
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BX — Other drugs affecting bone structure and mineralization (ATC, ATC/DDD)
- M05BX04 — DENOSUMAB (ATC/DDD)
Reference brand drug: Prolia, Xgeva
